Welcome back to Endpoints Weekly. Grab a cup of Saturday morning coffee and let’s dive straight into the news — it was a busy week!

Eli Lil­ly has shared first-in-hu­man re­sults for its se­lec­tive FGFR3 in­hibitor in a sub­set of blad­der can­cer pa­tients, mark­ing the start of a pro­gram that … ...

The Trump administration’s effort to remake the federal workforce swept through US healthcare agencies on Friday, with wide ...

Cor­bus Phar­ma­ceu­ti­cals re­port­ed en­cour­ag­ing ear­ly-stage re­sults for its Nectin-4 tar­get­ing ADC in var­i­ous types of can­cer, but a lack of re­sponse in cer­tain ...

Johnson & Johnson is set to push for confirmation of a bankruptcy plan next week that would settle a vast majority of cases ...

Renee Wegrzyn has been let go as the head of a federal agency that pursues ambitious ideas to accelerate biomedical ...

Major drugmakers are planning to meet with President Donald Trump next week at the White House as part of the industry’s ...